Status:
UNKNOWN
Multidisciplinary Approach to Reduce Cardiovascular Health Disparities
Lead Sponsor:
LifeBridge Health
Collaborating Sponsors:
University of Maryland
Conditions:
Acute Coronary Syndrome
Multi Vessel Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to investigate the potential differences in thrombogenicity between black and white patients admitted with atherothrombotic events including acute coronary synd...
Eligibility Criteria
Inclusion
- Patients ≥18 years of age admitted with ACS, AIS, or multi-vessel CAD
- Competent mental condition to provide informed consent and able to participate in follow-ups
Exclusion
- Pregnant women
- Currently enrolled in an investigational drug or device trial
- Undergoing treatment for neoplastic, autoimmune, or connective tissue disease
- COVID-19 infection within 30 days of enrollment
- Known history of hepatitis or HIV
- Deemed unfit to participate according to the investigator
- Known history of drug abuse
- Known platelet count of \<100,000/mm3
- Hematocrit \< 25%
Key Trial Info
Start Date :
February 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06168968
Start Date
February 6 2023
End Date
December 1 2025
Last Update
November 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sinai Hospital of Baltimore
Baltimore, Maryland, United States, 21215